Nikhil Prasad Fact checked by:Thailand Medical News Team Apr 16, 2026 3 days, 23 hours, 20 minutes ago
Medical News: A Breakthrough in Detecting Severe Diabetic Complications
Diabetes is widely known for causing long-term health problems, but one of its most dangerous complications is the development of foot ulcers that fail to heal. These wounds can rapidly deteriorate, leading to infections and, in severe cases, limb amputation. New research now suggests that tiny molecules circulating in the bloodstream could help identify patients at high risk much earlier than previously possible. This discovery could transform how doctors detect and manage one of the most devastating outcomes of diabetes.
Tiny blood molecules may help doctors detect amputation risk in diabetics before severe complications develop
What the Study Looked At
The study involved 101 participants divided into three groups: healthy individuals, patients with diabetic foot ulcers, and patients who had undergone lower limb amputations. Researchers analyzed blood samples to measure levels of microRNAs, which are small molecules that regulate gene activity and influence how cells behave. These molecules are known to play important roles in inflammation, blood vessel formation, and tissue repair, all of which are essential for proper wound healing.
The researchers were from the Department of Physiology at Instituto Nacional de Cardiología Ignacio Chávez, the Coordinación de Nutrición y Bioprogramación at Instituto Nacional de Perinatología, the Sección de Estudios de Posgrado at Escuela Superior de Medicina Instituto Politécnico Nacional, and the Unidad Xochimilco at Universidad Autónoma Metropolitana in Mexico. Their goal was to determine whether specific microRNAs could serve as early indicators of worsening diabetic complications.
Key Findings That Stand Out
The study found that four microRNAs - let-7e, miR-17, miR-33, and miR-191 - were significantly elevated in patients with diabetic foot ulcers and those who had undergone amputations compared to healthy individuals. Among these, miR-191 showed the most notable increase, especially in patients who had already experienced limb amputation. This suggests that higher levels of miR-191 may be linked to more severe disease progression.
The researchers also discovered important relationships between these microRNAs and common health indicators. Higher levels of certain microRNAs were associated with increased blood glucose levels, while others showed a negative relationship with good cholesterol levels. Some were also linked to higher total cholesterol and LDL cholesterol levels. These findings indicate that the microRNAs are closely tied to the metabolic imbalances seen in diabetes.
Why This Matters for Patients
This
Medical News report highlights a significant advancement in the potential early detection of severe diabetic complications. Currently, many patients are only treated aggressively once visible symptoms, such as ulcers, become severe. With the help of these molecular markers, doctors may
soon be able to identify high-risk patients much earlier using simple blood tests.
This could lead to earlier interventions, improved monitoring, and better outcomes for patients. In particular, miR-17 showed promising diagnostic accuracy, meaning it could help distinguish between individuals at different stages of disease risk.
Understanding the Bigger Picture
MicroRNAs act as powerful regulators in the body, controlling how genes are expressed and how cells respond to stress and damage. In people with diabetes, these regulatory systems often become disrupted, contributing to poor wound healing and chronic inflammation. The elevated levels of specific microRNAs observed in this study suggest that they may reflect deeper biological changes that occur before visible complications arise.
The research also highlighted that factors such as obesity, abnormal cholesterol levels, and chronic inflammation can further influence these molecular patterns. This means that patients with multiple metabolic risk factors may be more vulnerable to severe complications.
Conclusion
The study provides compelling evidence that circulating microRNAs, particularly miR-191, miR-17, and let-7e, may serve as early warning signals for severe diabetic complications such as foot ulcers and limb amputation. These molecules not only reflect disease severity but are also closely linked to key metabolic disturbances like high blood sugar and unhealthy cholesterol levels. While the findings are promising, further large-scale studies are needed to validate their clinical use. If confirmed, these biomarkers could play a crucial role in transforming how diabetes complications are detected and managed, potentially reducing the number of amputations and improving patient outcomes.
The study findings were published in the peer reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/27/8/3516
For the latest on diabetic amputations, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/diabetes
Share
Tweet
Share
